🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/01/2000 62,08 65,72 62,08 64,71 +3,93% 5,86% 7.963.018
04/01/2000 63,93 64,71 61,78 62,26 -3,51% 4,57% 7.894.689
03/01/2000 65,48 65,48 63,45 64,53 +0,65% 3,10% 6.265.782
31/12/1999 64,77 65,00 63,87 64,11 -0,92% 1,75% 2.595.267
30/12/1999 64,95 65,60 64,23 64,71 -0,64% 2,11% 3.488.897
29/12/1999 66,79 66,79 64,47 65,12 -2,15% 3,48% 3.598.727
28/12/1999 67,03 67,15 65,66 66,56 -1,06% 2,22% 3.745.447
27/12/1999 66,26 67,51 66,08 67,27 +1,08% 2,16% 3.455.990
23/12/1999 66,67 67,03 65,90 66,56 +3,81% 1,70% 4.157.730
22/12/1999 63,04 65,12 63,04 64,11 +1,70% 3,31% 4.995.921
21/12/1999 63,33 64,23 63,04 63,04 -0,84% 1,88% 5.671.357
20/12/1999 63,57 64,59 63,16 63,57 +0,09% 2,25% 5.414.911
17/12/1999 67,03 67,15 63,51 63,51 -4,14% 5,43% 11.673.043
16/12/1999 68,23 68,23 65,48 66,26 -3,14% 4,02% 5.145.051
15/12/1999 65,54 68,64 65,54 68,40 +2,87% 4,73% 6.999.487
14/12/1999 64,89 66,50 63,75 66,50 +2,11% 4,23% 7.688.442
13/12/1999 67,03 67,75 64,89 65,12 -4,46% 4,27% 8.108.376
10/12/1999 68,40 69,36 67,63 68,17 +0,35% 2,53% 5.540.986
09/12/1999 70,61 71,45 67,75 67,93 -2,88% 5,24% 5.099.254
08/12/1999 70,85 70,91 69,06 69,94 +0,15% 2,61% 5.423.400
07/12/1999 72,16 72,16 69,18 69,84 -3,28% 4,13% 5.723.652
06/12/1999 74,19 74,19 71,62 72,21 -2,20% 3,46% 4.663.286
03/12/1999 72,70 73,89 72,28 73,83 +2,65% 2,21% 4.616.440
02/12/1999 71,09 72,64 71,09 71,92 -1,33% 2,18% 3.638.761
01/12/1999 74,19 74,55 71,68 72,89 -2,92% 3,86% 4.425.390
30/11/1999 75,92 76,10 74,37 75,08 -1,64% 2,28% 4.273.010
29/11/1999 76,04 76,63 75,26 76,34 +0,16% 1,80% 4.656.788
26/11/1999 76,28 76,34 75,98 76,22 +0,24% 0,47% 2.155.002
24/11/1999 74,61 76,40 74,43 76,04 +1,92% 2,64% 4.391.644
23/11/1999 75,20 75,26 73,89 74,61 -0,69% 1,82% 2.606.166